Findings from OncoArendi Therapeutics SA Update Understanding of Idiopathic Pulmonary Fibrosis (Disc...
Findings from OncoArendi Therapeutics SA Update Understanding of Idiopathic Pulmonary Fibrosis (Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis)
About this item
Full title
Findings from OncoArendi Therapeutics SA Update Understanding of Idiopathic Pulmonary Fibrosis (Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis)
Publisher
NewsRX LLC
Journal title
Obesity, fitness, & wellness week, 2020-11, p.733
Language
English
Formats
Publication information
Publisher
NewsRX LLC
Subjects
More information
Alternative Titles
Full title
Findings from OncoArendi Therapeutics SA Update Understanding of Idiopathic Pulmonary Fibrosis (Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis)
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A640165356
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A640165356
Other Identifiers
ISSN
1531-6386
How to access this item
Log in as a Library member
